News
Breaking the link between prescription drug list prices and compensation to middlemen like pharmacy benefit managers (PBMs) ...
The Patented Medicine Prices Review Board’s mandate is to make sure that drug prices are not excessive. However, new ...
Delinking pharmacy middlemen compensation from list prices and shifting to transparent, fair payment models would reduce ...
7d
Zacks Investment Research on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.
Apollo Hospitals' board has approved a major restructuring involving the demerger and consolidation of its pharmacy and digital health units under Apollo Healthtech, which will be listed ...
These adjustments – accounting for market dynamics and purchasing power – offer a more nuanced view of how U.S. drug prices compare internationally. To be clear, the United States does pay more than ...
Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results